Does Haemonetics' (HAE) Hospital Rebound and NexSys Expansion Reframe Its Competitive Positioning?

In recent months, Haemonetics has reported a recovery in its Hospital division, supported by broader adoption of its ...

Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?

HAE's NexSys PCS adoption and hospital recovery signal growth ahead, but a leveraged balance sheet and stiff competition still cloud the stock's outlook.